切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2023, Vol. 12 ›› Issue (06) : 681 -687. doi: 10.3877/cma.j.issn.2095-3232.2023.06.017

临床研究

Alagille综合征疑诊为先天性胆道闭锁一例并文献复习
许丁伟, 马江云, 李新成, 黄洁()   
  1. 650101 昆明医科大学第二附属医院肝胆胰外科
  • 收稿日期:2023-07-27 出版日期:2023-12-10
  • 通信作者: 黄洁
  • 基金资助:
    云南省科技厅昆医联合专项(202001AY070001-229); 昆明医科大学第二附属医院院内研究项目(2020yk007)

Alagille syndrome misdiagnosed as congenital biliary atresia: a case report and literature review

Dingwei Xu, Jiangyun Ma, Xincheng Li, Jie Huang()   

  1. Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China
  • Received:2023-07-27 Published:2023-12-10
  • Corresponding author: Jie Huang
引用本文:

许丁伟, 马江云, 李新成, 黄洁. Alagille综合征疑诊为先天性胆道闭锁一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 681-687.

Dingwei Xu, Jiangyun Ma, Xincheng Li, Jie Huang. Alagille syndrome misdiagnosed as congenital biliary atresia: a case report and literature review[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(06): 681-687.

目的

探讨Alagille综合征的临床特征、诊疗方法及预后情况。

方法

回顾性分析2022年2月在昆明医科大学第二附属医院行手术治疗的1例疑诊先天性胆道闭锁后确诊Alagille综合征患儿临床资料。患儿男,10岁9个月,"因反复皮肤黄染伴瘙痒10年余,再发加重1周"于2021年11月以"先天性胆道闭锁"收入院。体检:发育明显障碍,头围偏小、前额突出,眼距中度增宽,尖下巴,四肢关节畸形。肝脏肋下3 cm触及,质软。ALT、AST、TB、DB、ALP、GGT等肝功能指标不同程度升高。MRCP示肝内胆管分支不清,未见扩张,肝外胆管纤细,特异性胆管炎可能。超声检查示胆管纤细,肝损伤声像。ERCP示胆总管线性狭窄、肝总管囊状扩张。检索万方、维普、CNKI、PubMed、MEDLINE数据库中儿童Alagille综合征相关文献,并进行总结分析。

结果

2021年11月25日患者行胆管支架胆道植入术,术后3 d腹痛剧烈,急诊行胆管支架取出,同时行PTCD。多学科讨论后行血液全外显子靶向捕获-高通道测序,结果显示JAG1基因的c.439C>T(p.Q147*)变异,JAG1基因的编码区域检测到1个杂合无义变异。该变异导致JAG1基因第147位密码子由编码谷氨酰胺变为终止密码子。根据患者存在JAG1基因突变,且有前额突出、眼距增宽的特殊面容和慢性胆汁淤积两种典型表现,明确诊断为ALGS。

结论

ALGS在临床中非常罕见,往往导致漏诊、误诊,且预后较差。基因检测普及使更多ALGS患者得到准确诊断,大部分患者由于心脏疾病或重症肝炎死亡,尚无良好的治疗方案,主要为对症支持治疗,肝移植可能是目前最好的治疗方案。

Objective

To investigate clinical characteristics, diagnosis, treatment and prognosis of Alagille syndrome (ALGS).

Methods

Clinical data of 1 child with ALGS misdiagnosed as congenital biliary atresia undergoing surgery in the Second Affiliated Hospital of Kunming Medical University in February 2022 were retrospectively analyzed. The boy, aged 10 years and 9 months, was admitted and diagnosed with "congenital biliary atresia" in our hospital in November 2021 due to "repeated yellow skin complicated with itching for more than 10 years and then aggravated for 1 week". Physical examination showed significant developmental disorder, small head circumference, prominent forehead, moderate hypertelorism, pointed chin and limb joint deformity. The liver was tender and palpable 3 cm below the right costal margin. ALT, AST, TB, DB, ALP, GGT levels and other liver function indexes were increased to varying degrees. MRCP showed that intrahepatic bile duct branches were unclear, no dilatation was found and extrahepatic bile ducts were thin. The possibility of specific cholangitis was considered. Ultrasound examination indicated the signs of thin bile ducts and liver injury. ERCP showed linear stenosis of common bile duct and cystic dilatation of common hepatic duct. Relevant studies of pediatric ALGS were searched from Wanfang Data, Chongqing VIP, CNKI, PubMed and MEDLINE and subject to literature review.

Results

On November 25, 2021, the patient underwent biliary stent implantation, and developed severe abdominal pain at postoperative 3 d. The biliary stent was emergently removed and PTCD was performed simultaneously. After multi-disciplinary team consultation, the whole-exome capture for targeted high-throughput sequencing detected c.439C>T (p.Q147*) mutation of JAG1 gene, and heterozygous nonsense mutation in the coding region of JAG1 gene, leading to the change of codon 147 of JAG1 gene from coding glutamine to stop codon. According to JAG1 gene mutation in combination with protruded forehead, two typical manifestations of hypertelorism and chronic cholestasis, the diagnosis of ALGS was confirmed.

Conclusions

ALGS is extremely rare in clinical practice, which is likely to be missed diagnosis and misdiagnosed. Clinical prognosis is relatively poor. With widespread application of genetic testing, more Alagille syndrome patients can be diagnosed accurately. Most patients die of heart disease or severe hepatitis. No effective treatment is available. Symptomatic treatment is mainly adopted. Liver transplantation is probably the optimal procedure.

表1 一例Alagille综合征患者临床检验结果
图1 一例ALGS患者影像学检查注:a、b为MRCP示肝外胆管纤细,c为ERCP示胆总管线性狭窄、肝总管囊状扩张;ALGS为Alagille综合征
图2 一例ALGS患者诊治情况注:a为CT示胆囊增大、胆囊内高密度影,考虑造影剂存留;b为ERCP取出胆管支架;c为PTCD造影示胆囊管、肝总管、胆总管纤细,肝内胆道充盈差;ALGS为Alagille综合征
图3 一例ALGS患者基因检测注:ALGS为Alagille综合征
表2 修订的ALGS诊断标准[4]
表3 经典ALGS征诊断标准[4]
[1]
Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome[J]. Nat Genet, 1997, 16(3):235-242.
[2]
Singh SP, Pati GK. Alagille syndrome and the liver: current insights[J]. Euroasian J Hepatogastroenterol, 2018, 8(2):140-147.
[3]
Saleh M, Kamath BM, Chitayat D. Alagille syndrome: clinical perspectives[J]. Appl Clin Genet, 2016(9):75-82.
[4]
Guru Murthy GS, Rana BS, Das A, et al. Alagille syndrome: a rare disease in an adolescent[J]. Digest Dis Sci, 2012, 57(11): 3035-3037.
[5]
Alagille D, Odièvre M, Gautier M, et al. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental, and sexual development, and cardiac murmur[J]. J Pediatr, 1975, 86(1):63-71.
[6]
McDaniell R, Warthen DM, Sanchez-Lara PA, et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway[J].Am J Hum Genet, 2006, 79(1):169-173.
[7]
Vajro P, Ferrante L, Paolella G. Alagille syndrome: an overview[J]. Clin Res Hepatol Gastroenterol, 2012, 36(3):275-277.
[8]
Leonard LD, Chao G, Baker A, et al. Clinical utility gene card for: Alagille syndrome (ALGS)[J]. Eur J Hum Genet, 2014, 22(3).
[9]
Alagille D, Estrada A, Hadchouel M, et al. Syndromic paucity of interlobular bile ducts (Alagille syndrome or arteriohepatic dysplasia): review of 80 cases[J]. J Pediatr, 1987, 110(2):195-200.
[10]
Kamath BM, Krantz ID, Spinner NB, et al. Monozygotic twins with a severe form of Alagille syndrome and phenotypic discordance[J]. Am J Med Genet, 2002, 112(2):194-197.
[11]
Shah I, Bhatnagar S, Dhabe H. Clinical and biochemical factors associated with biliary atresia[J]. Trop Gastroenterol, 2012, 33(3):214-217.
[12]
Rendón-Macías ME, Villasís-Keever MA, Castañeda-Muciño G, et al. Improvement in accuracy of gamma-glutamyl transferase for differential diagnosis of biliary atresia by correlation with age[J]. Turkish J Pediatr, 2008, 50(3):253-259.
[13]
Liu Y, Wang H, Dong C, et al. Clinical features and genetic analysis of pediatric patients with Alagille syndrome presenting initially with liver function abnormalities[J]. Curr Med Sci, 2018, 38(2):304-309.
[14]
Turnpenny PD, Ellard S. Alagille syndrome: pathogenesis, diagnosis and management[J]. Eur J Hum Genet, 2012, 20(3):251-257.
[15]
Subramaniam P, Knisely A, Portmann B, et al. Diagnosis of Alagille syndrome-25 years of experience at King's College Hospital[J]. J Pediatr Gastr Nutr, 2011, 52(1):84-89.
[16]
Arvay JL, Zemel BS, Gallagher PR, et al. Body composition of children aged 1 to 12 years with biliary atresia or Alagille syndrome[J]. J Pediatr Gastr Nutr, 2005, 40(2):146-150.
[17]
Tilib Shamoun S, Le Friec G, Spinner N, et al. Immune dysregulation in Alagille syndrome: a new feature of the evolving phenotype[J]. Clin Res Hepatol Gastroenterol, 2015, 39(5):566-569.
[18]
Li L, Krantz ID, Deng Y, et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1[J]. Nat Genet, 1997, 16(3):243-251.
[19]
Oda T, Elkahloun AG, Pike BL, et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome[J]. Nat Genet, 1997, 16(3):235-242.
[20]
Morrissette JD, Colliton RP, Spinner NB. Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome[J]. Hum Mol Genet, 2001, 10(4):405-413.
[21]
High FA, Lu MM, Pear WS, et al. Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development[J]. Proc Natl Acad Sci U S A, 2008, 105(6):1955-1959.
[22]
Tapia Ceballos L, Picazo Angelín B, Ruiz García C. Use of statins in children[J]. An Pediatr, 2008, 68(4):385-392.
[23]
Mozer-Glassberg Y, Hojsak I, Zevit N, et al. Pruritus responsive to naltrexone in a patient with cholestatic liver disease[J]. Isr Med Assoc J, 2011, 13(2):111-112.
[24]
Kamath BM, Yin W, Miller H, et al. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience[J]. Liver Transpl, 2012, 18(8):940-948.
[25]
Emerick KM, Rand EB, Goldmuntz E, et al. Features of Alagille syndrome in 92 patients: frequency and relation to prognosis[J]. Hepatology, 1999, 29(3):822-829.
[26]
中华医学会肝病学分会. 胆汁淤积性肝病管理指南(2021)[J]. 中华肝脏病杂志, 2022, 30(3):253-263.
[27]
Fawaz R, Baumann U, Ekong U, et al. Guideline for the evaluation of cholestatic jaundice in infants: joint recommendations of the North American Society for pediatric gastroenterology, hepatology, and nutrition and the European Society for pediatric gastroenterology, hepatology, and nutrition[J]. J Pediatr Gastr Nutr, 2017, 64(1):154-168.
[28]
詹春雷, 万盛华, 李娜, 等. 血浆氨基酸谱变化在Citrin缺陷致新生儿肝内胆汁淤积症诊断中的价值[J]. 中华实用儿科临床杂志, 2020, 35(14):1076-1080.
[29]
Chiang LW, Lee CY, Krishnaswamy G, et al. Seventeen years of Kasai portoenterostomy for biliary atresia in a single Southeast Asian paediatric centre[J]. J Paediatr Child Health, 2017, 53(4):412-415.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[6] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[7] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[8] 陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[9] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[10] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[11] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[12] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?